QuickView for Two pore domain potassium channel, TREK (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
2. L1000 CMAP - Adenocarcinoma of breast SKBR3 cells treated with ligand perturbagens
3. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
4. Neural development of iPSCs derived from Autistic patients with BCKD-kinase mutations
5. L1000 CMAP - Adipose MSC ASC52telo cells with shRNA-mediated gene knockdown

There were no matches for Two pore domain potassium channel, TREK

There were no clinical trials for Two pore domain potassium channel, TREK